Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.033 | 0.6 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |